Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darshan N Kasal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|October 26, 2020
Multi-transcription factor reporter mice delineate early precursors to the ILC and LTi lineagesDarshan N Kasal, Albert Bendelac
Nature Communications|December 2, 2017
Publisher Correction: A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage developmentAi-Ping Mao, Isabel E Ishizuka, Darshan N Kasal, et al.
Nature Communications|October 18, 2017
A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage developmentAi-Ping Mao, Isabel E Ishizuka, Darshan N Kasal, et al.
Annual Review of Immunology|January 26, 2024
Systemic Immune Modulation by Gastrointestinal NematodesDarshan N Kasal, Lindsey M Warner, Astra S Bryant, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2021
A <i>Gata3</i> enhancer necessary for ILC2 development and functionDarshan N Kasal, Zhitao Liang, Maile K Hollinger, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Frontiers in Immunology|May 18, 2026
ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TBEmily Voigt, Anas Alsharaydeh, Darshan N Kasal, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against <i>Mycobacterium tuberculosis</i> challenge in BCG-primed Collaborative Cross inbred miceEmily A Voigt, Anas Alsharaydeh, Darshan N Kasal, et al.
International Journal of Pharmaceutics|May 28, 2025
A spray dried replicon vaccine platform for pandemic responseWynton D McClary, John Z Chen, Hui Wang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|October 26, 2020
Multi-transcription factor reporter mice delineate early precursors to the ILC and LTi lineagesDarshan N Kasal, Albert Bendelac
Nature Communications|December 2, 2017
Publisher Correction: A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage developmentAi-Ping Mao, Isabel E Ishizuka, Darshan N Kasal, et al.
Nature Communications|October 18, 2017
A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage developmentAi-Ping Mao, Isabel E Ishizuka, Darshan N Kasal, et al.
Annual Review of Immunology|January 26, 2024
Systemic Immune Modulation by Gastrointestinal NematodesDarshan N Kasal, Lindsey M Warner, Astra S Bryant, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2021
A <i>Gata3</i> enhancer necessary for ILC2 development and functionDarshan N Kasal, Zhitao Liang, Maile K Hollinger, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Frontiers in Immunology|May 18, 2026
ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TBEmily Voigt, Anas Alsharaydeh, Darshan N Kasal, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against <i>Mycobacterium tuberculosis</i> challenge in BCG-primed Collaborative Cross inbred miceEmily A Voigt, Anas Alsharaydeh, Darshan N Kasal, et al.
International Journal of Pharmaceutics|May 28, 2025
A spray dried replicon vaccine platform for pandemic responseWynton D McClary, John Z Chen, Hui Wang, et al.
Pageof 2